122 related articles for article (PubMed ID: 17433707)
1. Role of caveolins in body weight and insulin resistance regulation.
Frühbeck G; López M; Diéguez C
Trends Endocrinol Metab; 2007 Jul; 18(5):177-82. PubMed ID: 17433707
[TBL] [Abstract][Full Text] [Related]
2. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
Hnasko R; Lisanti MP
Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis.
Le Lay S; Hajduch E; Lindsay MR; Le Lièpvre X; Thiele C; Ferré P; Parton RG; Kurzchalia T; Simons K; Dugail I
Traffic; 2006 May; 7(5):549-61. PubMed ID: 16643278
[TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin response in skeletal muscle cell by caveolin status.
Oh YS; Cho KA; Ryu SJ; Khil LY; Jun HS; Yoon JW; Park SC
J Cell Biochem; 2006 Oct; 99(3):747-58. PubMed ID: 16676355
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet.
Gómez-Ruiz A; de Miguel C; Campión J; Martínez JA; Milagro FI
FEBS Lett; 2009 Oct; 583(19):3259-64. PubMed ID: 19751730
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane cyclic nucleotide phosphodiesterase 3B (PDE3B) is associated with caveolae in primary adipocytes.
Nilsson R; Ahmad F; Swärd K; Andersson U; Weston M; Manganiello V; Degerman E
Cell Signal; 2006 Oct; 18(10):1713-21. PubMed ID: 16503395
[TBL] [Abstract][Full Text] [Related]
7. Role of caveolin and caveolae in insulin signaling and diabetes.
Cohen AW; Combs TP; Scherer PE; Lisanti MP
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1151-60. PubMed ID: 14607781
[TBL] [Abstract][Full Text] [Related]
8. Caveolae and caveolin in transmembrane signaling: Implications for human disease.
Schwencke C; Braun-Dullaeus RC; Wunderlich C; Strasser RH
Cardiovasc Res; 2006 Apr; 70(1):42-9. PubMed ID: 16412403
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.
Razani B; Combs TP; Wang XB; Frank PG; Park DS; Russell RG; Li M; Tang B; Jelicks LA; Scherer PE; Lisanti MP
J Biol Chem; 2002 Mar; 277(10):8635-47. PubMed ID: 11739396
[TBL] [Abstract][Full Text] [Related]
10. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease.
Xu Y; Buikema H; van Gilst WH; Henning RH
Eur J Pharmacol; 2008 May; 585(2-3):256-60. PubMed ID: 18423600
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 interacts and cooperates with the transforming growth factor-beta type I receptor ALK1 in endothelial caveolae.
Santibanez JF; Blanco FJ; Garrido-Martin EM; Sanz-Rodriguez F; del Pozo MA; Bernabeu C
Cardiovasc Res; 2008 Mar; 77(4):791-9. PubMed ID: 18065769
[TBL] [Abstract][Full Text] [Related]
12. Role of caveolae and caveolins in health and disease.
Cohen AW; Hnasko R; Schubert W; Lisanti MP
Physiol Rev; 2004 Oct; 84(4):1341-79. PubMed ID: 15383654
[TBL] [Abstract][Full Text] [Related]
13. Cell biology. Life without caveolae.
Parton RG
Science; 2001 Sep; 293(5539):2404-5. PubMed ID: 11577223
[No Abstract] [Full Text] [Related]
14. The association of caveolae, actin, and the dystrophin-glycoprotein complex: a role in smooth muscle phenotype and function?
Halayko AJ; Stelmack GL
Can J Physiol Pharmacol; 2005 Oct; 83(10):877-91. PubMed ID: 16333360
[TBL] [Abstract][Full Text] [Related]
15. Getting rid of caveolins: phenotypes of caveolin-deficient animals.
Le Lay S; Kurzchalia TV
Biochim Biophys Acta; 2005 Dec; 1746(3):322-33. PubMed ID: 16019085
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary analysis and molecular dissection of caveola biogenesis.
Kirkham M; Nixon SJ; Howes MT; Abi-Rached L; Wakeham DE; Hanzal-Bayer M; Ferguson C; Hill MM; Fernandez-Rojo M; Brown DA; Hancock JF; Brodsky FM; Parton RG
J Cell Sci; 2008 Jun; 121(Pt 12):2075-86. PubMed ID: 18505796
[TBL] [Abstract][Full Text] [Related]
17. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.
Matsuzaka T; Shimano H; Yahagi N; Kato T; Atsumi A; Yamamoto T; Inoue N; Ishikawa M; Okada S; Ishigaki N; Iwasaki H; Iwasaki Y; Karasawa T; Kumadaki S; Matsui T; Sekiya M; Ohashi K; Hasty AH; Nakagawa Y; Takahashi A; Suzuki H; Yatoh S; Sone H; Toyoshima H; Osuga J; Yamada N
Nat Med; 2007 Oct; 13(10):1193-202. PubMed ID: 17906635
[TBL] [Abstract][Full Text] [Related]
18. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide.
Hajduch E; Turban S; Le Liepvre X; Le Lay S; Lipina C; Dimopoulos N; Dugail I; Hundal HS
Biochem J; 2008 Mar; 410(2):369-79. PubMed ID: 17983354
[TBL] [Abstract][Full Text] [Related]
19. Raft association and lipid droplet targeting of flotillins are independent of caveolin.
Rajendran L; Le Lay S; Illges H
Biol Chem; 2007 Mar; 388(3):307-14. PubMed ID: 17338638
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 as a potential new therapeutic target in multiple myeloma.
Podar K; Anderson KC
Cancer Lett; 2006 Feb; 233(1):10-5. PubMed ID: 16473666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
